Total Funding
23
65
Total FundingPost-IPO Equity raised
Growth Score
13 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
201856
Scorpius Biomanufacturing is a CDMO specializing in mammalian, microbial, and cell therapies for biologics development and manufacturing.
- Shari Udoff-McDonald: Vice President, Business DevelopmentPast Role: BioReliance, Head of Commercial, North America-East
About the Company
Scorpius Biomanufacturing operates as an integrated contract development and manufacturing organization (CDMO) within the biotechnology industry. It specializes in the development and manufacturing of large molecules, offering services across mammalian, microbial, and cell therapies. The company focuses on providing comprehensive biologics
solutions, including clinical manufacturing projects for both mammalian and microbial products. Scorpius Biomanufacturing aims to support the biotechnology sector by offering capacity and expertise in the development and manufacturing of biologics and new modalities, catering to the needs of its clients from development through to manufacturing.
